Surrey Heartlands

Joint Formulary & PAD

GP

Immune thrombocytopenia

You are here : Home > Formulary Search > Immune thrombocytopenia

Documentation

Guidelines (Local)
USE OF THROMBOPOETIN RECEPTOR AGONISTS (TPO RAs) AND FOSTAMATINIB IN THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN ADULTS October 2024.pdf

Drugs

Below are listed all drugs that are used to treat Immune thrombocytopenia.

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approved the updated ITP pathway.

Guideline Profile

Indication :
Immune thrombocytopenia
Keywords :
ITP. avatrombopag, eltrombopag, fostamatinib, rituximab, romiplostim, IVIg, TPO-RA agonist
Brand Names Include :
Revolade, Doptelet, Tavlesse, MabThera, Rixathon, Truxima, Nplate,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1